JNJ10191584

• CAT Number: I006997
• CAS Number: 73903-17-0
• Molecular Formula: C13H15ClN4O
• Molecular Weight: 278.74
• Purity: ≥95%
• Synonyms: (6-chloro-1H-benzimidazol-2-yl)-(4-methylpiperazin-1-yl)methanone
• InChI: InChI=1S/C13H15ClN4O/c1-17-4-6-18(7-5-17)13(19)12-15-10-3-2-9(14)8-11(10)16-12/h2-3,8H,4-7H2,1H3,(H,15,16)
• InChIKey: MOIWSUQWIOVGRH-UHFFFAOYSA-N
• SMILES: CN1CCN(CC1)C(=O)C2=NC3=C(N2)C=C(C=C3)Cl

JNJ10191584（Cat No.:I006997）is a small molecule inhibitor developed to target specific kinases involved in inflammatory processes and immune system regulation. It acts by selectively inhibiting key enzymes in the JAK-STAT signaling pathway, which plays a crucial role in immune cell activation and the production of pro-inflammatory cytokines. This inhibition can reduce excessive immune responses, making JNJ10191584 a potential therapeutic for autoimmune diseases such as rheumatoid arthritis and psoriasis. Ongoing research is focused on evaluating its safety, efficacy, and potential for clinical use, particularly in inflammatory and autoimmune conditions.